These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 24141856

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro hydrolysis and transesterification of CDP323, an α4β1/α4β7 integrin antagonist ester prodrug.
    Chanteux H, Rosa M, Delatour C, Prakash C, Smith S, Nicolas JM.
    Drug Metab Dispos; 2014 Jan; 42(1):153-61. PubMed ID: 24179032
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors.
    Wang X, Wang G, Shi J, Aa J, Comas R, Liang Y, Zhu HJ.
    Pharmacogenomics J; 2016 Jun; 16(3):220-30. PubMed ID: 26076923
    [Abstract] [Full Text] [Related]

  • 6. Conclusive identification of the oxybutynin-hydrolyzing enzyme in human liver.
    Sato Y, Miyashita A, Iwatsubo T, Usui T.
    Drug Metab Dispos; 2012 May; 40(5):902-6. PubMed ID: 22293119
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Different hydrolases involved in bioactivation of prodrug-type angiotensin receptor blockers: carboxymethylenebutenolidase and carboxylesterase 1.
    Ishizuka T, Yoshigae Y, Murayama N, Izumi T.
    Drug Metab Dispos; 2013 Nov; 41(11):1888-95. PubMed ID: 23946449
    [Abstract] [Full Text] [Related]

  • 12. Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans.
    Yoshida T, Fukami T, Kurokawa T, Gotoh S, Oda A, Nakajima M.
    Eur J Pharm Sci; 2018 Jan 01; 111():167-176. PubMed ID: 28966098
    [Abstract] [Full Text] [Related]

  • 13. Effects of alcohol on human carboxylesterase drug metabolism.
    Parker RB, Hu ZY, Meibohm B, Laizure SC.
    Clin Pharmacokinet; 2015 Jun 01; 54(6):627-38. PubMed ID: 25511794
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase.
    Shimizu M, Fukami T, Nakajima M, Yokoi T.
    Drug Metab Dispos; 2014 Jul 01; 42(7):1103-9. PubMed ID: 24751575
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rapid conversion of the new angiotensin converting enzyme inhibitor ramipril to its active metabolite in rats.
    Tabata S, Yamazaki H, Ohtake Y, Hayashi S.
    Arzneimittelforschung; 1990 Aug 01; 40(8):865-7. PubMed ID: 2173610
    [Abstract] [Full Text] [Related]

  • 18. Carboxylesterase-2 plays a critical role in dabigatran etexilate active metabolite formation.
    Laizure SC, Chen F, Farrar JE, Ali D, Yang B, Parker RB.
    Drug Metab Pharmacokinet; 2022 Dec 01; 47():100479. PubMed ID: 36375226
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.